XBiotech Inc. (XBIT) Reaches $7.60 52-Week High; Lithia Motors, Inc. (LAD) Covered By 4 Bullish Analysts Last Week

XBiotech Inc. (NASDAQ:XBIT) Logo

The stock of XBiotech Inc. (NASDAQ:XBIT) hit a new 52-week high and has $7.98 target or 5.00% above today’s $7.60 share price. The 6 months bullish chart indicates low risk for the $272.23M company. The 1-year high was reported on Feb, 5 by Barchart.com. If the $7.98 price target is reached, the company will be worth $13.61 million more. The stock increased 4.97% or $0.36 during the last trading session, reaching $7.6. About 230,768 shares traded or 146.03% up from the average. XBiotech Inc. (NASDAQ:XBIT) has declined 7.38% since February 5, 2018 and is downtrending. It has underperformed by 7.38% the S&P500. Some Historical XBIT News: 22/05/2018 – XBiotech Announces First Patient in Phase 2 Study Evaluating MABp1 in Patients with Atopic Dermatitis; 02/04/2018 – XBIOTECH INC – OBTAINED AN EXCLUSIVE, WORLDWIDE LICENSE FROM CT ATLANTIC AG, A SWISS BIOTECHNOLOGY COMPANY; 16/04/2018 – XBIOTECH INC – CONDUCTING FINAL PREPARATIONS FOR STUDY LAUNCH INCLUDING FIRST CLINICAL SITE INITIATION SCHEDULED LATER THIS MONTH; 02/04/2018 – XBIOTECH INC – HAS OBTAINED AN EXCLUSIVE, WORLDWIDE LICENSE FROM CT ATLANTIC AG; 16/04/2018 – XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology; 02/04/2018 XBiotech In-licenses Anti-NY-ESO-1 Antibody Targeting Advanced Cancer; 02/04/2018 – XBIOTECH – WILL USE ITS TECHNOLOGY TO ADVANCE DEVELOPMENT OF TRUE HUMAN(TM )ANTI-NY-ESO-1 MONOCLONAL ANTIBODY, 12D7; 16/04/2018 – Press Release: XBiotech Announces Upcoming Phase 2 Clinical Studies in Dermatology; 20/04/2018 – DJ XBiotech Inc, Inst Holders, 1Q 2018 (XBIT); 02/04/2018 – XBIOTECH IN-LICENSES ANTI-NY-ESO-1 ANTIBODY FROM CT ATLANTIC

Among 4 analysts covering Lithia Motors (NYSE:LAD), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Lithia Motors had 5 analyst reports since August 15, 2018 according to SRatingsIntel. The firm has “Buy” rating by Buckingham Research given on Thursday, October 25. Morgan Stanley maintained Lithia Motors, Inc. (NYSE:LAD) on Wednesday, November 14 with “Overweight” rating. Guggenheim upgraded the shares of LAD in report on Friday, September 21 to “Buy” rating. As per Wednesday, October 24, the company rating was upgraded by Bank of America. On Wednesday, August 15 the stock rating was maintained by Morgan Stanley with “Overweight”. See Lithia Motors, Inc. (NYSE:LAD) latest ratings:

14/11/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $107 New Target: $108 Maintain
25/10/2018 Broker: Buckingham Research Old Rating: Buy New Rating: Buy Old Target: $100 New Target: $106 Maintain
24/10/2018 Broker: Bank of America Old Rating: Neutral New Rating: Buy Upgrade
21/09/2018 Broker: Guggenheim Old Rating: Neutral New Rating: Buy Upgrade
15/08/2018 Broker: Morgan Stanley Old Rating: Overweight New Rating: Overweight Old Target: $126 New Target: $107 Maintain

More notable recent Lithia Motors, Inc. (NYSE:LAD) news were published by: Seekingalpha.com which released: “Is Lithia Worth An Investment? – Seeking Alpha” on September 18, 2018, also Bizjournals.com with their article: “Lithia makes history with record-shattering quarter, investors gobble up shares – Portland Business Journal” published on October 24, 2018, Bizjournals.com published: “Lithia hits high-water marks during its second 2018 quarter – Portland Business Journal” on July 25, 2018. More interesting news about Lithia Motors, Inc. (NYSE:LAD) were released by: Zacks.com and their article: “Pick These 4 Stocks With Excellent Interest Coverage Ratio – Zacks.com” published on February 05, 2019 as well as Seekingalpha.com‘s news article titled: “Lithia announces strategic partnership with Shift Technologies – Seeking Alpha” with publication date: September 13, 2018.

Lithia Motors, Inc. operates automotive franchises, and retails new and used vehicles in the United States. The company has market cap of $2.08 billion. The firm operates in three divisions: Domestic, Import, and Luxury. It has a 7.43 P/E ratio. It sells new and used cars, replacement parts, vehicle service contracts, vehicle protection products, and credit insurance products; provides vehicle maintenance, warranty, paint, and repair services; and arranges related financing.

The stock decreased 0.56% or $0.5 during the last trading session, reaching $88.22. About 22,270 shares traded. Lithia Motors, Inc. (NYSE:LAD) has declined 41.21% since February 5, 2018 and is downtrending. It has underperformed by 41.21% the S&P500. Some Historical LAD News: 25/04/2018 – Lithia Motors 1Q Net $52.1M; 16/04/2018 – Lithia Motors May Benefit, Industry Posts 13th Straight Gain; 06/03/2018 Haig Partners Advises Prestige Family Of Fine Cars On Sale To Lithia Motors, Inc; 25/04/2018 – LITHIA BOOSTS QTR DIVIDEND TO 29C/SHR, EST. 30C; 25/04/2018 – LITHIA REAFFIRMS FORECAST; 25/04/2018 – LITHIA MOTORS 1Q ADJ EPS $2.07, EST. $2.29; 25/04/2018 – LITHIA MOTORS INC LAD.N SEES FY 2018 REVENUE $12 BLN TO $12.5 BLN; 25/04/2018 – LITHIA MOTORS INC LAD.N SEES FY 2018 SHR $10.60; 25/04/2018 – Lithia Motors Backs 2018 EPS $10.60; 25/04/2018 – Lithia Motors Raises Dividend to 29c

Investors sentiment decreased to 0.74 in Q3 2018. Its down 0.59, from 1.33 in 2018Q2. It fall, as 36 investors sold Lithia Motors, Inc. shares while 76 reduced holdings. 27 funds opened positions while 56 raised stakes. 24.10 million shares or 0.08% more from 24.08 million shares in 2018Q2 were reported. Commonwealth Financial Bank Of accumulated 3,700 shares or 0% of the stock. Aperio Group Inc Ltd Liability Corp reported 7,781 shares stake. Macquarie Group Limited has 29,799 shares. Bancorporation Of Montreal Can stated it has 661 shares or 0% of all its holdings. Wesbanco Commercial Bank holds 0.1% or 24,685 shares. Louisiana State Employees Retirement Sys invested in 0.04% or 10,200 shares. California State Teachers Retirement Systems accumulated 35,109 shares or 0.01% of the stock. Bluecrest Cap Management Ltd holds 0.01% or 5,333 shares in its portfolio. Cwm Ltd reported 52 shares or 0% of all its holdings. Hanson Mcclain reported 0% in Lithia Motors, Inc. (NYSE:LAD). Brinker Capital holds 6,927 shares. State Of Tennessee Treasury Department holds 0.01% or 13,136 shares in its portfolio. Tci Wealth Advisors has 0% invested in Lithia Motors, Inc. (NYSE:LAD) for 10 shares. Citadel Advsrs Lc invested 0% of its portfolio in Lithia Motors, Inc. (NYSE:LAD). Commerce Retail Bank holds 8,421 shares or 0.01% of its portfolio.

XBiotech Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing True Human monoclonal antibodies for treating various diseases. The company has market cap of $272.23 million. The companyÂ’s lead product is Xilonix, which is also known as MABp1, a therapeutic antibody that neutralizes interleukin-1 alpha, which has completed Phase III clinical trial in Europe for the treatment of symptomatic and advanced colorectal cancer. It currently has negative earnings. It has also investigating its lead product candidate in various clinical trials for other inflammatory conditions, including vascular disease, type II diabetes, acne, psoriasis, pyoderma gangrenosum, and hidradenitis suppurativa, as well as staphylococcus aureus infection, influenza, and clostridium difficile infection diseases.

More notable recent XBiotech Inc. (NASDAQ:XBIT) news were published by: Seekingalpha.com which released: “Subcutaneous formulation of XBiotech’s bermekimab successful in mid-stage study – Seeking Alpha” on January 23, 2019, also Nasdaq.com with their article: “Dr. Eric Simpson to Present Bermekimab Results in Atopic Dermatitis at 2019 AAD Annual Meeting – Nasdaq” published on January 29, 2019, Nasdaq.com published: “Dr. Alice Gottlieb to Present Hidradenitis Suppurativa Findings at American Academy of Dermatology Annual Meeting – Nasdaq” on January 28, 2019. More interesting news about XBiotech Inc. (NASDAQ:XBIT) were released by: Seekingalpha.com and their article: “XBiotech: Strong Upside Potential In Atopic Dermatitis And Hidradenitis Suppurativa – Seeking Alpha” published on January 23, 2019 as well as Globenewswire.com‘s news article titled: “XBiotech Highlights Quarterly Developments Nasdaq:XBIT – GlobeNewswire” with publication date: August 10, 2018.

Lithia Motors, Inc. (NYSE:LAD) Institutional Positions Chart

Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *